Development of Bioartificial Myocardium Using Stem Cells and Nanobiotechnology Templates

Figure 1

(a) MAGNUM Clinical Trial: Ischemic heart disease patient, 3D representation of the preoperative radioisotopic SPECT Tc^99m sestamibi imaging, showing the chronic infarction area (blue stain). (b) Same patient, followup at 18 months showing the improvement of myocardial viability and function (60% of reduction of the infarcted area, in blue) after stem cell therapy associated with the implantation onto the infarct scar of a cell-seeded collagen matrix.

(a)

(b)